-
-
Breast Cancer and the Use of Statins; Warnings Issued for IBS Drugs; FDA Actions.
-
With the muscle of an international cooperative group research network and expanded collaboration, confirmatory trials have been increasingly contemporaneously launched or provided important data in a timely fashion to help solidify important issues in the care of our patients.
-
The use of CEE conferred protection against fracture without an increase in breast cancer but with an increased risk of hypertension, stroke, and venous thromboembolism.
-
In this article, Adams and Nelson integrate results from several disparate fields to advance the concept that autoimmune conditions resemble host vs graft disease and that the graft in many cases may be fetal or maternal cells that lodge in the host, namely the mother or fetus, respectively.
-
Changes in screening, endocervical sampling, nomenclature, and improvements in treatment likely explain the increased in situ cervical SCC incidence in white and black women. Increasing AIS incidence over the past 20 years in white women has not yet translated into a decrease in invasive AC incidence.
-
Hormonal replacement therapy after breast canceris It Safe? (HABITS) began in May 1997, to compare breast cancer survivors treated for at least 2 years with hormone therapy with treatment other than hormones. By September 2003, a total of 434 women had been randomized and, in December 2003, the steering committee of the HABITS study made the decision to stop the trial because there were 26 women in the treated group and 7 in the non-treated group with new breast cancer diagnoses.
-
-
Most Americans believe that screening tests for cancer save lives and that it is irresponsible not to undergo recommended periodic screening. The presence of a large market for cancer screening may make Americans vulnerable to unproven and unnecessary testing.
-
Beksinska and colleagues from South Africa measured FSH levels in long-term older users of depot-medroxyprogesterone acetate (117 women) and norethindrone enanthate (60 women), long-acting progestin-only methods of contraception.
